- Research works
- 22 ▲ 1424% vs 2013–17
- Citations
- 255 11.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Aclaris Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Aclaris Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Immune Response, Inflammation, Cell Proliferation, Immunotherapy, Immunity and Gene Therapy.
- Ubiquitin
- Proteasome
- Epigenetic Regulation
- Tetrazoles
- Rituximab
- Immunosuppressive Therapy
- Anticancer Agents
- Medicinal Chemistry
- MAP Kinase
- BRAF gene
- Autoantibodies
- Diagnosis
- Melanoma
- Immunotherapy
- Cell Proliferation
- Immune Response
- Cancer Therapy
- Cancer
- Inflammation
- Epidemiology
- Immunity
- Gene Therapy
- Oncogenic Mutations
- Tumor Microenvironment
- Autoimmune
- Innate Immunity
- Cancer Immunotherapy
- Tumor Regression
- Catalysis
- NF-?B Activation
- Synthesis
- Bullous Pemphigoid
- Pemphigoid
- Tumor Targeting
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Cancer4▲ 12×11 topics
- Cancer Therapy3▲ 22×6 topics
- Inflammation3▲ 5.7×11 topics
- Immune Response3▲ 20×5 topics
- Epidemiology2▲ 2.6×11 topics
- Cell Proliferation2▲ 102×2 topics
- Immunity2▲ 25×5 topics
- Immunotherapy2▲ 13×5 topics
- Gene Therapy2▲ 30×3 topics
- Melanoma2▲ 156×2 topics
- Oncogenic Mutations2▲ 147×2 topics
- Diagnosis1▲ 6.2×3 topics
- Tumor Microenvironment1▲ 19×3 topics
- Autoantibodies1▲ 26×2 topics
- Autoimmune1▲ 119×2 topics
- BRAF gene1▲ 348×1 topic
- Innate Immunity1▲ 17×4 topics
- MAP Kinase1▲ 348×1 topic
- Cancer Immunotherapy1▲ 38×3 topics
- Medicinal Chemistry1▲ 15×4 topics
- Tumor Regression1▲ 62×2 topics
- Anticancer Agents1▲ 21×2 topics
- Catalysis1▲ 6.2×2 topics
- Immunosuppressive Therapy1▲ 26×2 topics
- NF-?B Activation1▲ 94×2 topics
- Rituximab1▲ 31×2 topics
- Synthesis1▲ 8.4×1 topic
- Tetrazoles1▲ 848×1 topic
- Bullous Pemphigoid1▲ 169×1 topic
- Epigenetic Regulation1▲ 21×2 topics
- Pemphigoid1▲ 169×1 topic
- Proteasome1▲ 116×1 topic
- Tumor Targeting1▲ 35×2 topics
- Ubiquitin1▲ 116×1 topic
Which research topics does Aclaris Therapeutics (United States) publish most on?
By volume in 2022–2025: Synthesis of Tetrazole Derivatives, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments and Cancer Cells and Metastasis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Synthesis of Tetrazole Derivatives Organic Chemistry 1 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 3 Cancer Research and Treatments Biotechnology 0 works
- 4 Cancer Cells and Metastasis Oncology 0 works
- 5 Immune cells in cancer Immunology 0 works
- 6 Inflammasome and immune disorders Molecular Biology 0 works
- 7 Biomarkers in Disease Mechanisms Immunology 0 works
- 8 Cancer-related gene regulation Molecular Biology 0 works
- 9 Melanoma and MAPK Pathways Molecular Biology 0 works
- 10 Cancer-related Molecular Pathways Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Aclaris Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 1424% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in St Louis
- Washington University in St. Louis
- Saint Louis University
- University of Missouri–St. Louis
- Washington University Medical Center
- Missouri Botanical Garden
- Barnes-Jewish Hospital
- St. Louis Children's Hospital
- Ophthalmology Associates (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.